The role of sorbents and probiotics in prevention of structural and morphological disorders in the small intestine of animals developing in dysbiosis

  • V.V. Bobyr O.O.Bogomolets National Medical University, Kyiv, Ukraine
  • L.O. Stechenko O.O.Bogomolets National Medical University, Kyiv, Ukraine
  • V.P. Shirobokov O.O.Bogomolets National Medical University, Kyiv, Ukraine
  • O.A. Nazarchuk National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • O.V. Rymsha National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: microbiota, probiotics, enterosorbents.

Abstract

The past decade is characterized by a noticeable increase in the interest of physicians in all areas of activity in the development of new and improvement of existing approaches to the correction of dysbiotic disorders. Among them, the concept of using probiotics occupies a leading position. At the same time, some enterosorbents, the mechanism of action of which is largely due to the sanitation of the intestinal lumen and due to this improvement of conditions for the vital activity of the physiological microbiota, can be attributed to the group of means of improving the normal microflora. In the context of an increase in the level of resistance to antibacterial agents, the inclusion of enterosorbents in the complex therapy of dysbiosis is an important and pathogenetically justified approach. The aim of the work was to clarify the effectiveness of the use of sorbents and probiotics for the prevention of structural and morphological disorders in the small intestine of white mice developing against the background of antibiotic-induced dysbiosis. Electron-microscopic methods showed that in the mucous membrane of the small intestine of mice after using the probiotic “Simbiter” the extinction of manifestations of cytodestructive disorders is observed. In addition, the obtained electron microscopic data, indicating the ability of probiotic drugs with the simultaneous introduction into the body of animals with a complex of antibiotics, to stimulate the body’s immune response. As a result of ultrastructural analysis of the mucous membrane of the small intestine of mice, the formation of dysbiosis in which occurred against the background of the use of enterosorbents, a decrease in the severity of structural damage was found, compared with the group of animals that received only antibiotics. After using “Symbiogel”, activation of plasma cells was registered, which can be an indicator of the inflammatory process and the activity of the immune response in general, as evidenced by the detection of plasma cells with dilated tubules. In general, it should be noted that the use of “Symbiogel” for the prevention of dysbiotic disorders contributes to the formation of a more pronounced immune response, compared with probiotic drugs. So, on the model of antibiotic-induced dysbiosis at the ultrastructural level, the ability of multiprobiotics “Simbiter®” and sorbent “Symbiogel” to reduce cytodestructive changes in the mucous membrane of the small intestine of mice and normalize morphoimunogenesis was proved.

References

[1] Barko, P. C., McMichael, M. A., Swanson, K. S., & Williams, D. A. (2018). The Gastrointestinal Microbiome: A Review. Journal of Veterinary Internal Medicine, 32(1), 9-25. https://doi.org/10.1111/jvim.14875
[2] Bengmark, S. (2013). Gut microbiota, immune development and function. Pharmacological research, 69(1), 87-113. https://doi.org/10.1016/j.phrs.2012.09.002
[3] Bobyr, V. V, Poniatovskyi, V. A, Dyuzhikova, O. M., & Shirobokov, V. P. (2015). Methods of modeling dysbiotic disorders in laboratory animals. Biomedical and Biosocial Anthropology, 26, 230-233.
[4] Harris, L. A., & Baffy, N. (2017). Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad. Med., 129(8), 872-888. doi: 10.1080/00325481.2017.1383819
[5] Heintz-Buschart, A., & Wilmes, P. (2018). Human Gut Microbiome: Function Matters. Trends in microbiology, 26(7), 563-574. https://doi.org/10.1016/j.tim.2017.11.002
[6] Howell, C. A., Mikhalovsky, S. V., Markaryan, E. N., & Khovanov, A. V. (2019). Investigation of the adsorption capacity of the enterosorbent Enterosgel for a range of bacterial toxins, bile acids and pharmaceutical drugs. Scientific reports, 9(1), 5629. https://doi.org/10.1038/s41598-019-42176-z
[7] Knight R., Callewaert Ch., Marotz C., Hyde E. R., Debelius J. W., McDonald D., Sogin M. L. (2017). The Microbiome and Human Biology. Annual Review of Genomics and Human Genetics, 18, 65-86. https://doi.org/10.1146/annurev-genom-083115-022438
[8] McNally, L., & Brown, S. P. (2015). Building the microbiome in health and disease: niche construction and social conflict in bacteria. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1675), 20140298. https://doi.org/10.1098/rstb.2014.0298.
[9] Mohajeri, M. H., Brummer, R., Rastall, R. A., Weersma, R. K., Harmsen, H., Faas, M., & Eggersdorfer, M. (2018). The role of the microbiome for human health: from basic science to clinical applications. European journal of nutrition, 57 (Suppl 1), 1-14. https://doi.org/10.1007/s00394-018-1703-4 .
[10] Nagpal, R., Mainali, R., Ahmadi, S., Wang, S., Singh, R., Kavanagh, K. … Yadav, H. (2018). Gut microbiome and aging: Physiological and mechanistic insights. Nutrition and healthy aging, 4(4), 267-285. https://doi.org/10.3233/NHA-170030.
[11] Pennisi, E. (2010). Body’s hardworking microbes get some overdue respect. Science, 330, 16-19. doi: 10.1126/science.330.6011.1619
[12] Preidis, G. A., & Versalovic, J. (2009). Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology, 136(6), 2015-2031. https://doi.org/10.1053/j.gastro.2009.01.072.
[13] Sakhnyuk, О. М., Surmasheva, O. V., Nastoyascha, N. I., Kryvoshlik, М. O., & Nikonova, N. O. (2011). Role of milk acidic bacteria for human dysbacteriosis correction and contemporary problems of probiotic preparations working out and hygienic estimation (literature survey). Hygiene of populated areas, 58, 373-383.
[14] Seidel, J., & Valenzano, D. R. (2018). The role of the gut microbiome during host ageing. F1000Research, 7, F1000 Faculty Rev-1086. https://doi.org/10.12688/f1000research.15121.1.
[15] Shirobokov, V. P., Yankovskyi, D. S., & Dyment, G. S. (2013). At the dawn of the origin of life: the role of clay minerals. Outlook, 39(1), 58-65.
[16] Shirobokov, V. P., Yankovskyi, D. S., & Dyment, G. S. (2012). The world of clays and human health. Outlook, 34(2), 6-17.
[17] Thomas, C., & Versalovic, J. (2010). Probiotics-host communication: modulation of signaling pathways in the intestine, Gut. Microbes, 1, 148-163.
[18] Tremaroli, V., & Bäckhed F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature, 489, 242-249 https://doi.org/10.1038/nature11552.
[19] Van Tassell, M. L., & Miller, M. J. (2011). Lactobacillus adhesion to mucus. Nutrients, 3(5), 613-636. https://doi.org/10.3390/nu3050613.
[20] Wang, M., Hearon, S. E., & Phillips, T. D. (2019). Development of enterosorbents that can be added to food and water to reduce toxin exposures during disasters. Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes, 54(6), 514-524. https://doi.org/10.1080/03601234.2019.1604039.
[21] Wang, M., Hearon, S. E., & Phillips, T. D. (2020). A high capacity bentonite clay for the sorption of aflatoxins. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 37(2), 332-341. https://doi.org/10.1080/19440049.2019.1662493.
[22] Wischmeyer, P. E., McDonald, D., & Knight, R. (2016). Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness. Current opinion in critical care, 22(4), 347-353. https://doi.org/10.1097/MCC.0000000000000321.
[23] Yankovskyi, D. S, Shirobokov, V. P, & Dyment, G. S. (2017). Microbiome. Kiev: FLP Veres O.I.
[24] Yankovskyi, D. S., Shirobokov, V. P., & Dyment, G. S. (2013). Creation of new complex preparations based on the biomass of probiotic bacteria and smectite gel. Prophylactic medicine, 21(3-4), 108-115.
[25] Yankovskyi, D. S., Shirobokov, V. P., & Dyment, G. S. (2018). Innovation technologies for human microbiome improvement. Science and Innovation, 14(6), 11-21. https://doi.org/10.15407/scine14.06.011
Published
2020-10-12
How to Cite
Bobyr, V., Stechenko, L., Shirobokov, V., Nazarchuk, O., & Rymsha, O. (2020). The role of sorbents and probiotics in prevention of structural and morphological disorders in the small intestine of animals developing in dysbiosis. Reports of Morphology, 26(2), 45-50. https://doi.org/10.31393/morphology-journal-2020-26(2)-07